Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1161/STROKEAHA.115.008818 | DOI Listing |
Hand (N Y)
December 2024
Department of Surgery, Division of Plastic Surgery, McMaster University, Hamilton, ON, Canada.
Background: Currently, there is no recommended standard set of outcomes to report in Dupuytren disease treatment studies, nor are there guidelines on how the outcomes themselves should be reported. This study aimed to elicit the most salient issues for patients living with and undergoing treatment for Dupuytren disease, as well as for the hand surgeons, occupational therapists, and physical therapists caring for these patients.
Methods: A qualitative, interpretive description study employing one-on-one semi-structured interviews was conducted.
Ophthalmic Plast Reconstr Surg
January 2025
Department of Ophthalmology and Visual Sciences, University of Michigan W.K. Kellogg Eye Center, Ann Arbor, Michigan, U.S.A.
A 54-year-old female with myelodysplastic syndrome on chemotherapy presented with 10 days of periocular erythema and edema worsening on oral antibiotics. Computed Tomography scan showed periorbital soft tissue swelling without postseptal extension or abscess. Intravenous broad-spectrum antibiotics were administered.
View Article and Find Full Text PDFInt J Surg Case Rep
December 2024
King Edward Medical University, Lahore 54000, Punjab, Pakistan.
Introduction And Importance: Trichobezor is a mass of accumulated ingested hair in the gastric lumen. Rapunzel syndrome is an extension of these bezoars beyond the pylorus. The formation of trichobezoar is invariably linked to trichotillomania and trichophagia.
View Article and Find Full Text PDFPLoS One
December 2024
Department of Surgery, Division of Ophthalmology, McMaster University, Hamilton, Ontario, Canada.
Objective: Cataracts are the leading cause of global preventable and treatable blindness. Cystoid macular edema (CME) is among the most common complications following cataract surgery. The development of CME impacts patients' quality of life and has economic implications for patients and healthcare systems.
View Article and Find Full Text PDFJ Alzheimers Dis
December 2024
F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Background: Gantenerumab is a fully human anti-amyloid-β (Aβ) immunoglobulin G1 monoclonal antibody for subcutaneous (SC) administration. The efficacy and safety of low-dose (105 mg or 225 mg) gantenerumab were investigated in SCarlet RoAD (SR; NCT01224106), a Phase III, double-blind (DB), placebo-controlled study in participants with prodromal Alzheimer's disease. Following a pre-planned futility analysis, SR was converted into an open-label extension (OLE) study.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!